Company: INSP
Filing Date: 2025-03-18
Form Type: DEF 14A
Source: 0001140361-25-009249
Chunk: 72

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-03-18
Form: DEF 14A
Chunk 72
---
 by his son as to which Mr. Ban disclaims beneficial ownership. |

| (10) | Includes for Mr. Phillips, 23,916 shares of common stock underlying stock options currently exercisable or exercisable within 60 days of March 4, 2025. |

| Inspire Medical Systems, Inc. |     | 62 |     | 2025 Proxy Statement |

TABLE OF CONTENTS

| STOCK OWNERSHIP |

| (11) | Includes for Mr. Ellis, 11,180 shares of common stock underlying stock options currently exercisable or exercisable within 60 days of March 4, 2025. |

| (12) | Includes for Ms. Broader, 5,531 shares of common stock underlying stock options currently exercisable or exercisable within 60 days of March 4, 2025. |

| (13) | Includes for Ms. Garinois-Melenikiotou, 4,974 shares of common stock underlying stock options currently exercisable or exercisable within 60 days of March 4, 2025. |

| (14) | Includes for Mr. Weatherby, 3,223 shares of common stock underlying stock options currently exercisable or exercisable within 60 days of March 4, 2025. |

| (15) | Includes for Ms. Burks, 1,216 shares of common stock underlying stock options currently exercisable or exercisable within 60 days of March 4, 2025. |

| (16) | Includes for all executive officers and directors as a group, 494,608 shares of common stock underlying stock options currently exercisable or exercisable within 60 days of March 4, 2025. |

Delinquent Section 16(a) Reports Section 16(a) of the Exchange Act requires our executive officers and directors, our principal accounting officer and persons who beneficially own more than 10% of our common stock to file with the SEC reports of their ownership and changes in their ownership of our common stock. To our knowledge, based solely on review of the copies of such reports and amendments to such reports with respect to the year ended December 31, 2024 filed with the SEC and on written representations by our directors and executive officers, all required Section 16 reports under the Exchange Act for our directors, executive officers, principal accounting officer, and beneficial owners of greater than 10% of our common stock were filed on a timely basis during the year ended December